As of November 2024 Oryzon Genomics has a market cap of A$0.16 Billion. This makes Oryzon Genomics the world's 8715th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.